Tissue factor (TF) is the predominant physiological initiator of coagulation, and its regulation is a critical aspect of endothelial cell hemostatic function. This report describes the regulation of TF mRNA expression by two physiological agonists: minimally oxidized low-density lipoprotein (MM-LDL), which may modulate endothelial hemostatic function in atherosclerosis, and lipopolysaccharide (LPS), which is a mediator of septic shock. Northern blot analysis of total RNA from human endothelial cells exposed to either MM-LDL or LPS for varying times showed that TF mRNA increased sharply at 1 hour, peaked at 2 to 3 hours, and declined to basal levels by 6 to 8 hours after treatment. The half-life of TF mRNA in MM-LDL-and LPS-exposed endothelial cells was approximately 45 minutes and 40 minutes, respectively.
V ascular endothelial cells actively participate in the regulation of hemostasis. Under normal conditions, these cells are usually thromboresistant, a state that is maintained by controlling the expression of procoagulant factors as well as through the activity of several antithrombotic mechanisms. Tissue factor (TF), which is the cellular receptor and cofactor for coagulation factor VII/VHa, is the predominant initiator of the coagulation cascade. 1 Factor VIIa-TF complex activates both coagulation factors X and IX, ultimately leading to thrombin production. 2 In vivo, TF expression by normal endothelium is undetectable, and cultured endothelial cells also express no or low levels of TF. However, the hemostatic balance may be shifted in perturbed endothelial cells to promote thrombosis through the induction of TF activity and other changes. 3 Cultured endothelial cells can be induced to express TF by a variety of agonists, including bacterial lipopolysaccharide (LPS), 4 -5 certain inflammatory cytokines (interleukin-1, 6 tumor necrosis factor [TNF] 7 ), oxidized low-density lipoprotein (LDL), 8 ' 9 thrombin, 1011 immune complexes, 12 vascular permeability factor, 13 and phorbol ester, 14 suggesting that TF expression plays a role in various pathological processes. 1516 We have recently demonstrated 17 endothelial cell expression of TF in experimentally induced septic shock in baboons, thus showing the in vivo relevance of these studies. Increased expression of TF by endothelium, monocytes, or other cells is also thought to play a role in the pathogenesis of atherosclerosis, 1819 systemic lupus erythematosus, 20 diabetes, 21 and cancer. 22 -23 Despite the variety of agonists shown to induce TF expression, few studies have described the regulation of TF mRNA in endothelial cells. Only two physiological agonists have been examined (LPS and TNF), with somewhat differing results as to the relative importance of transcriptional activation versus modulation of mRNA stability. 14 - 24 We previously reported 8 that TF is induced in cultured human cardiac valve and aortic endothelial cells by minimally oxidized LDL (MM-LDL), 8 a recently described agonist believed to play a central role in the pathogenesis of atherosclerosis.
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The regulatory mechanism of TF expression by MM-LDL is unknown. In this study, we examined the regulation of TF mRNA by MM-LDL and compared it with regulation by LPS.
of Sparrow et al 28 with soybean lipoxygenase and phospholipase A 2 bound to cyanogen bromide-activated Sepharose beads. This enzymatic modification produced a low level of oxidation of LDL resulting in only a two-to threefold increase in conjugated dienes, an increase similar to that seen after Fe 2+ oxidation. All preparations were screened for LPS contamination by using a Limulus lysate assay, and all had <0.05 ng/mg LDL protein. Preparations were used at concentrations of 20 or 50 /xg LDL protein/mL.
Cell Culture
Human cardiac valve endothelial cells were isolated as described previously. 4 Cells were maintained in medium 199 (M199) supplemented with 20% fetal bovine serum (FBS), 292 /xg/mL glutamine, 110 tig/mL sodium pyruvate, 50 jug/mL endothelial cell growth supplement, 90 /xg/mL heparin, 100 U/mL penicillin, and 100 /xg/mL streptomycin. Cells were used at passages five through seven, 2 to 3 days after passage at confluent density. Medium was removed and monolayers were washed twice with M199, then incubated with the relevant agonists in M199 plus 10% FBS for varying times. LPS was from Escherichia coli O111:B4 (List Biological Laboratory, Inc, Campbell, Calif).
Tissue Factor Protein Quantification
Cells were grown to confluence in 24-well tissueculture dishes. After incubation with relevant agonists, cells were washed twice with cold PBS and once with TSA buffer (20 mmol/L tris[hydroxymethyl]aminomethane [Tris], pH 7.4, 130 mmol/L NaCl, and 0.1% bovine serum albumin). They were scraped into 200 /xL TSA buffer and freeze/thawed three times in a dry ice-ethanol bath. TF was measured by functional activity using the one-stage plasma recalcification time assay. 8 Specificity of this assay for TF was shown by preincubation of cells with an inhibitory antibody to TF that blocked the activity by >90%. 8 
RNA Isolation and Northern or Slot Blot Analysis
Total RNA was isolated from endothelial cells by using the acid guanidinium thiocyanate-phenol-chloroform extraction method. 29 For Northern blot analysis, isolated total RNA was denatured, and 10 tig RNA per lane was electrophoresed in a 1.2% formaldehydeagarose gel. Gels were soaked in 20x saline-sodium citrate (SSC) for 2 hours, and RNA was transferred to nylon membranes in 20 x SSC overnight. For slot blot analysis, RNA was denatured, and 5 /xg total RNA was loaded on each slot. Membranes were baked at 80°C for 2 hours and prehybridized in 7% sodium dodecyl sulfate (SDS), 0.5 mol/L sodium phosphate, pH 7.2, 1 mmol/L EDTA, 1% bovine serum albumin, and 100 /xg/mL sheared salmon sperm DNA for 2 hours at 65°C. 32 P-labeled cDNA probes were then added, and hybridizations were performed for 16 hours at 65°C. Membranes were washed once in 2x SSC and 0.1% SDS at room temperature for 15 minutes, once in 1 x SSC and 0.1% SDS at 65°C for 15 minutes, and once in 0.2x SSC and 0.1% SDS at 65°C for 10 minutes. Membranes were exposed to Kodak XMR film at -70°C by using intensifying screens for various times, and the properly exposed films were analyzed. The densities of specific autoradiographic signals were quantified by using a SciScan 5000 laser densitometer (United States Biochemical, Cleveland, Ohio).
cDNA Preparation
Clone pcTF1764, containing 1.28 kb human TF cDNA (provided by Dr Thomas Edgington of the Scripps Research Institute, La Jolla, Calif, and Dr James Morrissey of the Oklahoma Medical Research Foundation, Oklahoma City, Okla 30 ) was grown, and plasmids were isolated as described. 31 A 775-bp fragment was released from the plasmid by EcoRl digestion 32 and was used as a TF cDNA probe. CHO-B and a-actin cDNA probes were used as controls to normalize the TF signals in Northern blot and nuclear runoff assays, respectively. CHO-B is an abundant, constitutively expressed mRNA originally detected in Chinese hamster ovary cells, the expression of which in endothelial cells is unaltered by agonists such as LPS. 33 TF and CHO-B cDNA probes were labeled with [a-
32 P]dATP (7000 Ci/mmol) by the random primer method. 34 
Nuclear Runoff Transcription Assay
Cells were grown to confluence in 75-cm 2 cell-culture flasks, and nuclei were prepared as described. 35 Nuclear runoff transcription assays were performed as described. 36 Briefly, nuclear pellets were resuspended in 90 fiL nuclear storage buffer (50 mmol/L Tris-HCl, pH 8. 32 P]UTP (3000 Ci/mmol) were added to the nuclear preparation, which was then incubated at room temperature for 20 minutes. DNA was digested by 1 /xL of 20 000 U/mL RNase-free DNase at room temperature for 5 minutes, and 10 /xL yeast tRNA (10 mg/mL) was then added. The labeled RNA was isolated by extraction with guanidine thiocyanate-phenol-chloroform. RNA was precipitated with 1 volume of isopropanol, washed with 70% ethanol, and redissolved in 500 itL of 20 mmol/L Tris-HCl, pH 7.9, and 20 mmol/L EDTA. Membranes for the nuclear runoff assay were prepared by applying 2 t i g linearized plasmid DNA containing human TF or a-actin cDNA to each slot as described by the manufacturers (Schleicher & Schuell, Keene, NH). Membranes were baked at 80°C for 2 hours. Prehybridization and hybridization solutions were prepared as described. 35 Membranes were prehybridized at 65°C for 2 hours and were then hybridized with the isolated RNA from the nuclear runoff assays at 65°C for 48 hours. Membranes were washed once in 2x SSC and 0.1% SDS at room temperature for 15 minutes, once in 2x SSC, 0.1% SDS, and 10 tig/mL RNase A at 37°C for 20 minutes, and once in 0.2 x SSC and 0.1% SDS at 65°C for 10 minutes. Membranes were exposed to films, and autoradiographic signals were quantified as described for Northern blot analysis.
Immunofluorescence Microscopy
Cells were grown on gelatin-coated cover slips in 24-well culture dishes. After incubation with relevant agonists or control medium, the cells were fixed with 2% paraformaldehyde in PBS for 15 minutes at room temperature and were then permeabilized by immersion in 100% methanol at -20°C for 1 minute. The fixed cells were incubated with mouse anti-human TF antibody (provided by Dr Thomas Edgington and Dr James Morrissey 37 ) at 37°C for 1 hour. Bound antibody was detected by using the ABC Elite system (Vector Labs, Burlingame, Calif) with fluorescein isothiocyanate-conjugated avidin in the third stage. Fluorescence photomicroscopy was performed with a Zeiss Axioscope epifluorescence microscope with a 63 x oil objective, numerical aperture 1.25, with Kodak Tri-X pan 400 film.
Results

Time Course of TF Protein Activity and TF Antigen Expression
The time course of TF protein activity in human cardiac valve endothelial cells after MM-LDL or LPS stimulation is shown in Fig 1. TF protein activity began to appear 2 hours after exposure. Maximal activity occurred at 4 to 8 hours in MM-LDL-induced cells and between 4 to 6 hours in LPS-induced cells. TF protein activity returned to basal level by 24 hours after stimulation. The presence of TF antigen in the stimulated cells paralleled the time course of TF activity. Fig 1 also shows fluorescence micrographs of anti-TF monoclonal antibody localization in endothelial cells treated with 1 /u,g/mL LPS over time. TF antigen was undetectable in unstimulated endothelial cells. After 1 to 2 hours of exposure, antigen was weakly detectable throughout the cells, but also focally concentrated in a perinuclear distribution consistent with endoplasmic reticulum and Golgi apparatus localization. At 6 hours after exposure, there was substantially greater fluorescence, which was uniformly dispersed over the cells. By 24 hours, no fluorescence was detectable. The pattern of TF antigen expression after agonist exposure is consistent with stimulation of de novo protein synthesis and the induction of functional activity. As previously reported, unmodified LDL caused no significant increase in TF expression. Although MM-LDL preparations contained less than 0.05 ng endotoxin per milligram MM-LDL, the possibility that LPS contamination may have been responsible for the effect observed with MM-LDL was further addressed by subjecting the MM-LDL and LPS preparations to either heat (boiling for 5 minutes) or polymyxin B treatment (Fig 2) . Polymyxin B treatment, which would bind free LPS in the preparation, had no effect on MM-LDL induction, but it essentially abolished LPS activity. Polymyxin B itself did not affect TF activity in endothelial cells (data not shown). Further evidence for the absence of significant levels of LPS was obtained by heat treatment, which precipitates 90% of the lipid and 98% of the protein moieties of LDL and releases LPS potentially bound to the lipoprotein. 38 Residual TF-inducing activity was less than 20% that of untreated MM-LDL preparations, but there was little effect on LPS activity. These studies, taken together, strongly suggest that the induction of TF by MM-LDL preparations is not attributable to LPS contamination. Heat treatment inhibited the induction of TF activity by MM-LDL but not by LPS, whereas polymyxin B significantly inhibited the induction of TF activity by LPS but not by MM-LDL.
Time Course of TF mRNA Accumulation in Human Endothelial Cells
Human endothelial cells were stimulated with 20 UglmL MM-LDL or 1 /ug/mL LPS for varying periods of time, and TF mRNA accumulation was studied by Northern blot analysis. Fig 3 shows the results of a representative experiment (1 of 3 performed). TF mRNA had one major TF transcript (2.4 kb), representing the mature TF mRNA, and two minor transcripts (3.5 and 3.1 kb), which have been reported to result from alternative splicing. 39 The minor transcripts have been observed in several cultured cell types but not in tissues. The time course of TF mRNA expression was correlated with that of TF protein with a time delay for protein expression. TF mRNA was barely detectable in unstimulated cells. It sharply increased within 1 hour of stimulation and reached peak levels at 2 to 3 hours in both MM-LDL-and LPS-induced endothelial cells. Thereafter, TF mRNA levels declined more rapidly in endothelial cells induced by LPS than in those induced by MM-LDL. TF mRNA returned to near basal levels at 6 hours after exposure to LPS and at 8 hours after exposure to MM-LDL (data not shown).
Effects of MM-LDL and LPS on TF mRNA Stability
The stability of TF mRNA in endothelial cells was examined at 1 hour or 4 hours after the addition of MM-LDL or LPS, when mRNA levels were sharply increasing or decreasing, respectively. Cells were treated with either 50 /tg/mL MM-LDL or 1 /ig/mL LPS for 1 hour or 4 hours, followed by addition of 5 mg/mL actinomycin D to arrest gene transcription. TF mRNA levels were determined by Northern blot analysis at various times up to 90 minutes after the addition of actinomycin D. There was no significant difference in TF mRNA stability after a 1-hour stimulation compared with its stability after a 4-hour stimulation with either MM-LDL or LPS (Fig 4 shows a representative results of two and three experiments for MM-LDL and LPS, respectively). The average half-life of TF mRNA was approximately 45 minutes in MM-LDL-stimulated cells and 40 minutes in LPS-stimulated cells 1 hour and 4 hours after the addition of the agonists. Incubation of endothelial cells with 1 ju,g/mL LPS and 5 /xg/mL actinomycin D together for 1 hour or 4 hours completely inhibited the expression of TF mRNA (data not shown), indicating that gene transcription is required for the induction of TF mRNA by LPS and that the concentration of actinomycin D used is sufficient to completely inhibit gene transcription. Actinomycin D has been reported to stabilize chimeric )3-globin transcripts containing destabilizing elements from TF mRNA but not native TF mRNA. 40 
Effect of MM-LDL and LPS on Transcriptional Control of TF mRNA
Transcription of the TF gene in endothelial cells was studied by nuclear runoff analysis. Cells treated with 50 tiglmL MM-LDL or 1 /xg/mL LPS for 1 hour had an increased rate of TF gene transcription. However, the rate of TF gene transcription was not affected in native LDL-treated cells compared with control cells (Fig 5  shows a representative result of three experiments) . Densitometric analysis, with normalization of the TF signal to the corresponding a-actin signal, showed that the increase in the rate of TF gene transcription in both MM-LDL-and LPS-induced cells was approximately 16-fold relative to control cells.
Effects of Cycloheximide on the Expression of TF mRNA and Protein
The effects of cycloheximide, an inhibitor of protein synthesis, on the expression of TF mRNA and protein were examined. Fig 6 shows TF mRNA accumulation in the presence or absence of cycloheximide by slot blot analysis. The addition of cycloheximide enhanced the expression of TF mRNA in endothelial cells stimulated with MM-LDL or LPS. Also, unstimulated endothelial cells had increased levels of TF mRNA in the presence of cycloheximide. These findings indicate that transcriptional activation is not dependent on de novo protein synthesis, as has been described for a variety of genes. Superinduction of TF mRNA by cycloheximide, which is observed for a variety of inflammatory mediators and cytokines, 4143 is consistent with its described inhibitory action on the synthesis of a short-acting RNase. 44 Induction of TF protein activity, however, was reduced over 90% in the presence of cycloheximide (data not shown). In this study, we examined how a third physiological agonist, MM-LDL, regulated TF expression and compared it with regulation by LPS. Our data indicated that TF gene transcription in endothelial cells is significantly increased by both agonists. Although one report found only limited induction of TF gene transcription in LPS-treated endothelial cells, our findings are consistent with results reported for TNF and phorbol 12-myristate 13-acetate (PMA) using umbilical vein endothelial cells 14 and for LPS in monocytes. 45 - 46 Elegant studies in monocytic cell line THP-1 define an LPS response element in the promoter region of the TF gene that includes both nuclear factor-/<B and AP-1 consensus sequences. 47 Nuclear factor-«B has been shown to be induced in endothelial cells by exposure to LPS and MM-LDL, 27 ' 47 suggesting that this response element may play a role in TF regulation in endothelial cells also. The inability of cycloheximide, a protein synthesis inhibitor, to block TF mRNA induction is consistent with transcriptional activation occurring via transcription factors such as nuclear factor-/<B, the activation of which is independent of protein synthesis. We conclude from our findings and those of others that increased gene transcription plays a major role in induction of TF expression in endothelial cells and monocytes by MM-LDL and LPS.
TF mRNA is rapidly degraded in cells, with reported half-lives of from 25 to 90 minutes in various cells. and MM-LDL-stimulated endothelial cells, respectively, are quite similar to that of 48 minutes reported in PMA-stimulated endothelial cells. 24 In common with a variety of other inducible short-lived mRNAs, sequences in the 3' untranslated region of TF mRNA confer relatively rapid turnover in cells. By using various constructs of portions of the TF and /3-globin messages transfected into NIH/3T3 cells, Ahern et al 40 have defined an approximately 600-nucleotide sequence in the 3' untranslated region of TF mRNA that is responsible for the short half-life and that contains 79% (A+U) content and four copies of the AUUUA pentamer. The mechanisms by which this or related destabilizing sequences in mRNA rapid turnover act are not well understood. The phenomenon of superinduction of various short-lived mRNAs by cycloheximide, which is also observed for TF, is postulated to occur through message stabilization, 40 probably as a result of cycloheximide's blocking the synthesis of a rapidly degraded RNase. 44 Physiological upregulation of mRNA levels through transient stabilization of mRNA has been described for a variety of transcripts, 42 -44 including TF in LPS-stimulated human umbilical vein endothelial cells 14 and monocyte-like THP-1 cells. 45 We sought to confirm this phenomenon in LPS-and MM-LDL-stimulated human cardiac valve endothelial cells. Since there is negligible TF mRNA in unstimulated endothelial cells, by necessity stability studies were performed 1 and 4 hours after stimulation, as others have done. However, we found no prolongation of half-life in repeated experiments in these cells with either agonist, and we conclude that transient stabilization of TF message may be particularly dependent on cell type and/or experimental conditions. Although message stabilization is clearly an important means of mRNA induction, it occurs variably among genes, cells, and agonists. Insufficient information is available to assess whether this is a generally cpm for medium and LPS samples; 2x10 6 cpm for LDL and MM-LDL samples) was hybridized to nylon membranes containing 2 /u,g/slot a-actin or TF cDNA. Top, Autoradiograph of nuclear runoff blots. Signals were quantified by densitometric scanning, and TF signal was normalized by the corresponding a-actin signal. Bottom, Bar graph of relative rate of TF gene transcription expressed as fold induction compared with control cells.
occurring phenomenon in endothelial cells or with TF. The mechanisms by which agonist-induced mRNA stabilization may occur are also not well-defined. One mechanism described in peripheral blood mononuclear cells stimulated with phorbol ester is the rapid activation of a cytoplasmic factor that binds AU-rich sequences, 48 with evidence for such binding's protecting against endonuclease digestion. 49 The presence of this kind of activity in agonist-treated endothelial cells or its interaction with TF mRNA has not been reported.
The body minimizes the risk of intravascular activation of coagulation by limiting the constitutive expression of TF to selected cells not normally in contact with blood. 50 Of the cells that are normally in contact with blood, only endothelial cells and monocytes can be induced to express TF through a number of stimuli. Our work and that of others suggests that primary regulation occurs at the level of gene transcription, with additional control maintained by rapid degradation of mRNA. Induction of TF by agonists is initiated by activation of transcription, with mRNA stabilization playing a role in some settings, the extent of which has yet to be defined. Endothelial cell expression of TF is considered to be important in the pathogenesis of atherosclerosis 1819 and septic shock 17 ; hence the interest in MM-LDL, LPS, and TNF as relevant agonists. Elucidating mechanisms of signal transduction and transcriptional activation for these agonists will be important for expanding our understanding of the regulation of TF expression in these diseases.
